S 1803
115th Congress
Senate
Crime and Law Enforcement
Administrative law and regulatory procedures
Alternative treatments
Drug safety, medical device, and laboratory regulation
Drug therapy
Drug trafficking and controlled substances
Health personnel
Licensing and registrations
Medical research
Research administration and funding
MEDS Act
Introduced: September 13, 2017
See on congress.gov
Everywhere this bill has been
2 steps
Introduced
In committee
Reported out
Passed House
Passed Senate
To President
Became law
Sep 13, 2017
Read twice and referred to the Committee on the Judiciary. (Sponsor introductory remarks on measure: CR S5483-5484)
Sep 13, 2017
Introduced in Senate
Plain-English summary
Marijuana Effective Drug Studies Act of 2017 or the MEDS Act
This bill amends the Controlled Substances Act to establish a new, separate registration process to facilitate research involving marijuana and the commercial production of drugs made from marijuana.
Specifically, the bill requires the Drug Enforcement Administration to register manufacturers and distributors to supply marijuana: (1) for use in research, and (2) for the commercial production of approved drugs containing or derived from marijuana.
What's happening now
Read twice and referred to the Committee on the Judiciary. (Sponsor introductory remarks on measure: CR S5483-5484)
Committees of jurisdiction
1